Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
10.08
+0.65 (6.89%)
At close: Oct 8, 2025, 4:00 PM EDT
10.15
+0.07 (0.69%)
After-hours: Oct 8, 2025, 7:58 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Precision Medicines
53.88M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
53.88M